The GOG Foundation, Inc. and GOG Partners physician leadership will provide an educational symposium to physicians to increase clinicians’ knowledge and competence regarding the various targeted drug conjugates available. Our expert leaders will share the emerging data and outline how to integrate these treatments into clinical practice.
The GOG Foundation, Inc. is grateful for our commercial supporters for their unrestricted educational grants associated with this Symposium: ImmunoGen, Mersana, Genmab and Seagen Inc.